Request for Covid-19 Impact Assessment of this Report
The United States Ketorolac Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Ketorolac Injection market, reaching US$ million by the year 2028. As for the Europe Ketorolac Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Ketorolac Injection players cover Pfizer, Fresenius Kabi, Fosun Pharma (Gland Pharma), and Sagent Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketorolac Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by concentration: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
15mg/ml
30mg/ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Fresenius Kabi
Fosun Pharma (Gland Pharma)
Sagent Pharmaceuticals
Hikma
Lunan Pharma
Alvogen
Chengdu Brilliant Pharmaceuticals
Athenex
Sichuan Medcalo
Julphar Bangladesh Ltd.
Yung Shin Pharm
Tianjin Chase Sun Pharmaceutical
ZISKA Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ketorolac Injection Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Ketorolac Injection by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Ketorolac Injection by Country/Region, 2017, 2022 & 2028
2.2 Ketorolac Injection Segment by Concentration
2.2.1 15mg/ml
2.2.2 30mg/ml
2.3 Ketorolac Injection Sales by Concentration
2.3.1 Global Ketorolac Injection Sales Market Share by Concentration (2017-2022)
2.3.2 Global Ketorolac Injection Revenue and Market Share by Concentration (2017-2022)
2.3.3 Global Ketorolac Injection Sale Price by Concentration (2017-2022)
2.4 Ketorolac Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Others
2.5 Ketorolac Injection Sales by Application
2.5.1 Global Ketorolac Injection Sale Market Share by Application (2017-2022)
2.5.2 Global Ketorolac Injection Revenue and Market Share by Application (2017-2022)
2.5.3 Global Ketorolac Injection Sale Price by Application (2017-2022)
3 Global Ketorolac Injection by Company
3.1 Global Ketorolac Injection Breakdown Data by Company
3.1.1 Global Ketorolac Injection Annual Sales by Company (2020-2022)
3.1.2 Global Ketorolac Injection Sales Market Share by Company (2020-2022)
3.2 Global Ketorolac Injection Annual Revenue by Company (2020-2022)
3.2.1 Global Ketorolac Injection Revenue by Company (2020-2022)
3.2.2 Global Ketorolac Injection Revenue Market Share by Company (2020-2022)
3.3 Global Ketorolac Injection Sale Price by Company
3.4 Key Manufacturers Ketorolac Injection Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ketorolac Injection Product Location Distribution
3.4.2 Players Ketorolac Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ketorolac Injection by Geographic Region
4.1 World Historic Ketorolac Injection Market Size by Geographic Region (2017-2022)
4.1.1 Global Ketorolac Injection Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Ketorolac Injection Annual Revenue by Geographic Region
4.2 World Historic Ketorolac Injection Market Size by Country/Region (2017-2022)
4.2.1 Global Ketorolac Injection Annual Sales by Country/Region (2017-2022)
4.2.2 Global Ketorolac Injection Annual Revenue by Country/Region
4.3 Americas Ketorolac Injection Sales Growth
4.4 APAC Ketorolac Injection Sales Growth
4.5 Europe Ketorolac Injection Sales Growth
4.6 Middle East & Africa Ketorolac Injection Sales Growth
5 Americas
5.1 Americas Ketorolac Injection Sales by Country
5.1.1 Americas Ketorolac Injection Sales by Country (2017-2022)
5.1.2 Americas Ketorolac Injection Revenue by Country (2017-2022)
5.2 Americas Ketorolac Injection Sales by Concentration
5.3 Americas Ketorolac Injection Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ketorolac Injection Sales by Region
6.1.1 APAC Ketorolac Injection Sales by Region (2017-2022)
6.1.2 APAC Ketorolac Injection Revenue by Region (2017-2022)
6.2 APAC Ketorolac Injection Sales by Concentration
6.3 APAC Ketorolac Injection Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ketorolac Injection by Country
7.1.1 Europe Ketorolac Injection Sales by Country (2017-2022)
7.1.2 Europe Ketorolac Injection Revenue by Country (2017-2022)
7.2 Europe Ketorolac Injection Sales by Concentration
7.3 Europe Ketorolac Injection Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ketorolac Injection by Country
8.1.1 Middle East & Africa Ketorolac Injection Sales by Country (2017-2022)
8.1.2 Middle East & Africa Ketorolac Injection Revenue by Country (2017-2022)
8.2 Middle East & Africa Ketorolac Injection Sales by Concentration
8.3 Middle East & Africa Ketorolac Injection Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ketorolac Injection
10.3 Manufacturing Process Analysis of Ketorolac Injection
10.4 Industry Chain Structure of Ketorolac Injection
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ketorolac Injection Distributors
11.3 Ketorolac Injection Customer
12 World Forecast Review for Ketorolac Injection by Geographic Region
12.1 Global Ketorolac Injection Market Size Forecast by Region
12.1.1 Global Ketorolac Injection Forecast by Region (2023-2028)
12.1.2 Global Ketorolac Injection Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ketorolac Injection Forecast by Concentration
12.7 Global Ketorolac Injection Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Ketorolac Injection Product Offered
13.1.3 Pfizer Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Fresenius Kabi
13.2.1 Fresenius Kabi Company Information
13.2.2 Fresenius Kabi Ketorolac Injection Product Offered
13.2.3 Fresenius Kabi Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Fresenius Kabi Main Business Overview
13.2.5 Fresenius Kabi Latest Developments
13.3 Fosun Pharma (Gland Pharma)
13.3.1 Fosun Pharma (Gland Pharma) Company Information
13.3.2 Fosun Pharma (Gland Pharma) Ketorolac Injection Product Offered
13.3.3 Fosun Pharma (Gland Pharma) Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Fosun Pharma (Gland Pharma) Main Business Overview
13.3.5 Fosun Pharma (Gland Pharma) Latest Developments
13.4 Sagent Pharmaceuticals
13.4.1 Sagent Pharmaceuticals Company Information
13.4.2 Sagent Pharmaceuticals Ketorolac Injection Product Offered
13.4.3 Sagent Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sagent Pharmaceuticals Main Business Overview
13.4.5 Sagent Pharmaceuticals Latest Developments
13.5 Hikma
13.5.1 Hikma Company Information
13.5.2 Hikma Ketorolac Injection Product Offered
13.5.3 Hikma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hikma Main Business Overview
13.5.5 Hikma Latest Developments
13.6 Lunan Pharma
13.6.1 Lunan Pharma Company Information
13.6.2 Lunan Pharma Ketorolac Injection Product Offered
13.6.3 Lunan Pharma Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Lunan Pharma Main Business Overview
13.6.5 Lunan Pharma Latest Developments
13.7 Alvogen
13.7.1 Alvogen Company Information
13.7.2 Alvogen Ketorolac Injection Product Offered
13.7.3 Alvogen Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Alvogen Main Business Overview
13.7.5 Alvogen Latest Developments
13.8 Chengdu Brilliant Pharmaceuticals
13.8.1 Chengdu Brilliant Pharmaceuticals Company Information
13.8.2 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Offered
13.8.3 Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Chengdu Brilliant Pharmaceuticals Main Business Overview
13.8.5 Chengdu Brilliant Pharmaceuticals Latest Developments
13.9 Athenex
13.9.1 Athenex Company Information
13.9.2 Athenex Ketorolac Injection Product Offered
13.9.3 Athenex Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Athenex Main Business Overview
13.9.5 Athenex Latest Developments
13.10 Sichuan Medcalo
13.10.1 Sichuan Medcalo Company Information
13.10.2 Sichuan Medcalo Ketorolac Injection Product Offered
13.10.3 Sichuan Medcalo Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sichuan Medcalo Main Business Overview
13.10.5 Sichuan Medcalo Latest Developments
13.11 Julphar Bangladesh Ltd.
13.11.1 Julphar Bangladesh Ltd. Company Information
13.11.2 Julphar Bangladesh Ltd. Ketorolac Injection Product Offered
13.11.3 Julphar Bangladesh Ltd. Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Julphar Bangladesh Ltd. Main Business Overview
13.11.5 Julphar Bangladesh Ltd. Latest Developments
13.12 Yung Shin Pharm
13.12.1 Yung Shin Pharm Company Information
13.12.2 Yung Shin Pharm Ketorolac Injection Product Offered
13.12.3 Yung Shin Pharm Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Yung Shin Pharm Main Business Overview
13.12.5 Yung Shin Pharm Latest Developments
13.13 Tianjin Chase Sun Pharmaceutical
13.13.1 Tianjin Chase Sun Pharmaceutical Company Information
13.13.2 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Offered
13.13.3 Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Tianjin Chase Sun Pharmaceutical Main Business Overview
13.13.5 Tianjin Chase Sun Pharmaceutical Latest Developments
13.14 ZISKA Pharmaceuticals
13.14.1 ZISKA Pharmaceuticals Company Information
13.14.2 ZISKA Pharmaceuticals Ketorolac Injection Product Offered
13.14.3 ZISKA Pharmaceuticals Ketorolac Injection Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 ZISKA Pharmaceuticals Main Business Overview
13.14.5 ZISKA Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
Table 1. Ketorolac Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Ketorolac Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 15mg/ml
Table 4. Major Players of 30mg/ml
Table 5. Global Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 6. Global Ketorolac Injection Sales Market Share by Concentration (2017-2022)
Table 7. Global Ketorolac Injection Revenue by Concentration (2017-2022) & ($ million)
Table 8. Global Ketorolac Injection Revenue Market Share by Concentration (2017-2022)
Table 9. Global Ketorolac Injection Sale Price by Concentration (2017-2022) & (US$/K Units)
Table 10. Global Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 11. Global Ketorolac Injection Sales Market Share by Application (2017-2022)
Table 12. Global Ketorolac Injection Revenue by Application (2017-2022)
Table 13. Global Ketorolac Injection Revenue Market Share by Application (2017-2022)
Table 14. Global Ketorolac Injection Sale Price by Application (2017-2022) & (US$/K Units)
Table 15. Global Ketorolac Injection Sales by Company (2020-2022) & (K Units)
Table 16. Global Ketorolac Injection Sales Market Share by Company (2020-2022)
Table 17. Global Ketorolac Injection Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Ketorolac Injection Revenue Market Share by Company (2020-2022)
Table 19. Global Ketorolac Injection Sale Price by Company (2020-2022) & (US$/K Units)
Table 20. Key Manufacturers Ketorolac Injection Producing Area Distribution and Sales Area
Table 21. Players Ketorolac Injection Products Offered
Table 22. Ketorolac Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Ketorolac Injection Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Ketorolac Injection Sales Market Share Geographic Region (2017-2022)
Table 27. Global Ketorolac Injection Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Ketorolac Injection Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Ketorolac Injection Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Ketorolac Injection Sales Market Share by Country/Region (2017-2022)
Table 31. Global Ketorolac Injection Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Ketorolac Injection Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 34. Americas Ketorolac Injection Sales Market Share by Country (2017-2022)
Table 35. Americas Ketorolac Injection Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Ketorolac Injection Revenue Market Share by Country (2017-2022)
Table 37. Americas Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 38. Americas Ketorolac Injection Sales Market Share by Concentration (2017-2022)
Table 39. Americas Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 40. Americas Ketorolac Injection Sales Market Share by Application (2017-2022)
Table 41. APAC Ketorolac Injection Sales by Region (2017-2022) & (K Units)
Table 42. APAC Ketorolac Injection Sales Market Share by Region (2017-2022)
Table 43. APAC Ketorolac Injection Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Ketorolac Injection Revenue Market Share by Region (2017-2022)
Table 45. APAC Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 46. APAC Ketorolac Injection Sales Market Share by Concentration (2017-2022)
Table 47. APAC Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 48. APAC Ketorolac Injection Sales Market Share by Application (2017-2022)
Table 49. Europe Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 50. Europe Ketorolac Injection Sales Market Share by Country (2017-2022)
Table 51. Europe Ketorolac Injection Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Ketorolac Injection Revenue Market Share by Country (2017-2022)
Table 53. Europe Ketorolac Injection Sales by Type (2017-2022) & (K Units)
Table 54. Europe Ketorolac Injection Sales Market Share by Concentration (2017-2022)
Table 55. Europe Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 56. Europe Ketorolac Injection Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Ketorolac Injection Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Ketorolac Injection Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Ketorolac Injection Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Ketorolac Injection Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Ketorolac Injection Sales by Concentration (2017-2022) & (K Units)
Table 62. Middle East & Africa Ketorolac Injection Sales Market Share by Concentration (2017-2022)
Table 63. Middle East & Africa Ketorolac Injection Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Ketorolac Injection Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Ketorolac Injection
Table 66. Key Market Challenges & Risks of Ketorolac Injection
Table 67. Key Industry Trends of Ketorolac Injection
Table 68. Ketorolac Injection Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Ketorolac Injection Distributors List
Table 71. Ketorolac Injection Customer List
Table 72. Global Ketorolac Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Ketorolac Injection Sales Market Forecast by Region
Table 74. Global Ketorolac Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Ketorolac Injection Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Ketorolac Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Ketorolac Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Ketorolac Injection Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Ketorolac Injection Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Ketorolac Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Ketorolac Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Ketorolac Injection Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Ketorolac Injection Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Ketorolac Injection Sales Forecast by Concentration (2023-2028) & (K Units)
Table 85. Global Ketorolac Injection Sales Market Share Forecast by Concentration (2023-2028)
Table 86. Global Ketorolac Injection Revenue Forecast by Concentration (2023-2028) & ($ Millions)
Table 87. Global Ketorolac Injection Revenue Market Share Forecast by Concentration (2023-2028)
Table 88. Global Ketorolac Injection Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Ketorolac Injection Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Ketorolac Injection Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Ketorolac Injection Revenue Market Share Forecast by Application (2023-2028)
Table 92. Pfizer Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Pfizer Ketorolac Injection Product Offered
Table 94. Pfizer Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 95. Pfizer Main Business
Table 96. Pfizer Latest Developments
Table 97. Fresenius Kabi Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Fresenius Kabi Ketorolac Injection Product Offered
Table 99. Fresenius Kabi Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 100. Fresenius Kabi Main Business
Table 101. Fresenius Kabi Latest Developments
Table 102. Fosun Pharma (Gland Pharma) Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. Fosun Pharma (Gland Pharma) Ketorolac Injection Product Offered
Table 104. Fosun Pharma (Gland Pharma) Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 105. Fosun Pharma (Gland Pharma) Main Business
Table 106. Fosun Pharma (Gland Pharma) Latest Developments
Table 107. Sagent Pharmaceuticals Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Sagent Pharmaceuticals Ketorolac Injection Product Offered
Table 109. Sagent Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 110. Sagent Pharmaceuticals Main Business
Table 111. Sagent Pharmaceuticals Latest Developments
Table 112. Hikma Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 113. Hikma Ketorolac Injection Product Offered
Table 114. Hikma Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 115. Hikma Main Business
Table 116. Hikma Latest Developments
Table 117. Lunan Pharma Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 118. Lunan Pharma Ketorolac Injection Product Offered
Table 119. Lunan Pharma Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 120. Lunan Pharma Main Business
Table 121. Lunan Pharma Latest Developments
Table 122. Alvogen Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 123. Alvogen Ketorolac Injection Product Offered
Table 124. Alvogen Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 125. Alvogen Main Business
Table 126. Alvogen Latest Developments
Table 127. Chengdu Brilliant Pharmaceuticals Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 128. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Product Offered
Table 129. Chengdu Brilliant Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 130. Chengdu Brilliant Pharmaceuticals Main Business
Table 131. Chengdu Brilliant Pharmaceuticals Latest Developments
Table 132. Athenex Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 133. Athenex Ketorolac Injection Product Offered
Table 134. Athenex Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 135. Athenex Main Business
Table 136. Athenex Latest Developments
Table 137. Sichuan Medcalo Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 138. Sichuan Medcalo Ketorolac Injection Product Offered
Table 139. Sichuan Medcalo Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 140. Sichuan Medcalo Main Business
Table 141. Sichuan Medcalo Latest Developments
Table 142. Julphar Bangladesh Ltd. Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 143. Julphar Bangladesh Ltd. Ketorolac Injection Product Offered
Table 144. Julphar Bangladesh Ltd. Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 145. Julphar Bangladesh Ltd. Main Business
Table 146. Julphar Bangladesh Ltd. Latest Developments
Table 147. Yung Shin Pharm Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 148. Yung Shin Pharm Ketorolac Injection Product Offered
Table 149. Yung Shin Pharm Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 150. Yung Shin Pharm Main Business
Table 151. Yung Shin Pharm Latest Developments
Table 152. Tianjin Chase Sun Pharmaceutical Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 153. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Product Offered
Table 154. Tianjin Chase Sun Pharmaceutical Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 155. Tianjin Chase Sun Pharmaceutical Main Business
Table 156. Tianjin Chase Sun Pharmaceutical Latest Developments
Table 157. ZISKA Pharmaceuticals Basic Information, Ketorolac Injection Manufacturing Base, Sales Area and Its Competitors
Table 158. ZISKA Pharmaceuticals Ketorolac Injection Product Offered
Table 159. ZISKA Pharmaceuticals Ketorolac Injection Sales (K Units), Revenue ($ Million), Price (US$/K Units) and Gross Margin (2020-2022)
Table 160. ZISKA Pharmaceuticals Main Business
Table 161. ZISKA Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Ketorolac Injection
Figure 2. Ketorolac Injection Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Ketorolac Injection Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Ketorolac Injection Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Ketorolac Injection Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 15mg/ml
Figure 10. Product Picture of 30mg/ml
Figure 11. Global Ketorolac Injection Sales Market Share by Concentration in 2021
Figure 12. Global Ketorolac Injection Revenue Market Share by Concentration (2017-2022)
Figure 13. Ketorolac Injection Consumed in Hospital
Figure 14. Global Ketorolac Injection Market: Hospital (2017-2022) & (K Units)
Figure 15. Ketorolac Injection Consumed in Clinics
Figure 16. Global Ketorolac Injection Market: Clinics (2017-2022) & (K Units)
Figure 17. Ketorolac Injection Consumed in Others
Figure 18. Global Ketorolac Injection Market: Others (2017-2022) & (K Units)
Figure 19. Global Ketorolac Injection Sales Market Share by Application (2017-2022)
Figure 20. Global Ketorolac Injection Revenue Market Share by Application in 2021
Figure 21. Ketorolac Injection Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Ketorolac Injection Revenue Market Share by Company in 2021
Figure 23. Global Ketorolac Injection Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Ketorolac Injection Revenue Market Share by Geographic Region in 2021
Figure 25. Global Ketorolac Injection Sales Market Share by Region (2017-2022)
Figure 26. Global Ketorolac Injection Revenue Market Share by Country/Region in 2021
Figure 27. Americas Ketorolac Injection Sales 2017-2022 (K Units)
Figure 28. Americas Ketorolac Injection Revenue 2017-2022 ($ Millions)
Figure 29. APAC Ketorolac Injection Sales 2017-2022 (K Units)
Figure 30. APAC Ketorolac Injection Revenue 2017-2022 ($ Millions)
Figure 31. Europe Ketorolac Injection Sales 2017-2022 (K Units)
Figure 32. Europe Ketorolac Injection Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Ketorolac Injection Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Ketorolac Injection Revenue 2017-2022 ($ Millions)
Figure 35. Americas Ketorolac Injection Sales Market Share by Country in 2021
Figure 36. Americas Ketorolac Injection Revenue Market Share by Country in 2021
Figure 37. United States Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Ketorolac Injection Sales Market Share by Region in 2021
Figure 42. APAC Ketorolac Injection Revenue Market Share by Regions in 2021
Figure 43. China Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Ketorolac Injection Sales Market Share by Country in 2021
Figure 50. Europe Ketorolac Injection Revenue Market Share by Country in 2021
Figure 51. Germany Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Ketorolac Injection Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Ketorolac Injection Revenue Market Share by Country in 2021
Figure 58. Egypt Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Ketorolac Injection Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Ketorolac Injection in 2021
Figure 64. Manufacturing Process Analysis of Ketorolac Injection
Figure 65. Industry Chain Structure of Ketorolac Injection
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...